A federal judge in Massachusetts denied a pharmaceutical manufacturer's request for business interruption coverage after an air leak at the plant caused a $30 million loss of a Pfizer drug due to mold exposure, finding the alleged losses weren't covered by "direct physical loss of or damage to property."
Biotech & Pharmaceuticals
August 19, 2024, 6:11 PM